Cargando…

Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time

BACKGROUND AND PURPOSE: Reduction of respiratory tumour motion is important in liver stereotactic body radiation therapy (SBRT) to reduce side effects and improve tumour control probability. We have assessed the distribution of use of voluntary exhale breath hold (EBH), abdominal compression (AC), f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardcastle, Nicholas, Gaudreault, Mathieu, Yeo, Adam U., Ungureanu, Elena, Markham, Cathy, Barnes, Rebecca, Chander, Sarat, Chu, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841271/
https://www.ncbi.nlm.nih.gov/pubmed/36655214
http://dx.doi.org/10.1016/j.phro.2022.12.004
_version_ 1784869795691233280
author Hardcastle, Nicholas
Gaudreault, Mathieu
Yeo, Adam U.
Ungureanu, Elena
Markham, Cathy
Barnes, Rebecca
Chander, Sarat
Chu, Julie
author_facet Hardcastle, Nicholas
Gaudreault, Mathieu
Yeo, Adam U.
Ungureanu, Elena
Markham, Cathy
Barnes, Rebecca
Chander, Sarat
Chu, Julie
author_sort Hardcastle, Nicholas
collection PubMed
description BACKGROUND AND PURPOSE: Reduction of respiratory tumour motion is important in liver stereotactic body radiation therapy (SBRT) to reduce side effects and improve tumour control probability. We have assessed the distribution of use of voluntary exhale breath hold (EBH), abdominal compression (AC), free breathing gating (gating) and free breathing (FB), and the impact of these on treatment time. MATERIALS AND METHODS: We assessed all patients treated in a single institution with liver SBRT between September 2017 and September 2021. Data from pre-simulation motion management assessment using fluoroscopic assessment of liver dome position in repeat breath holds, and motion with and without AC, was reviewed to determine liver dome position consistency in EBH and the impact of AC on motion. Treatment time was assessed for all fractions as time from first image acquisition to last treatment beam off. RESULTS: Of 136 patients treated with 145 courses of liver SBRT, 68 % were treated in EBH, 20 % with AC, 7 % in gating and 5 % in FB. AC resulted in motion reduction < 1 mm in 9/26 patients assessed. Median treatment time was higher using EBH (39 min) or gating (42 min) compared with AC (30 min) or FB (24 min) treatments. CONCLUSIONS: Motion management in liver SBRT needs to be assessed per-patient to ensure appropriate techniques are applied. Motion management significantly impacts treatment time therefore patient comfort must also be taken into account when selecting the technique for each patient.
format Online
Article
Text
id pubmed-9841271
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98412712023-01-17 Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time Hardcastle, Nicholas Gaudreault, Mathieu Yeo, Adam U. Ungureanu, Elena Markham, Cathy Barnes, Rebecca Chander, Sarat Chu, Julie Phys Imaging Radiat Oncol Original Research Article BACKGROUND AND PURPOSE: Reduction of respiratory tumour motion is important in liver stereotactic body radiation therapy (SBRT) to reduce side effects and improve tumour control probability. We have assessed the distribution of use of voluntary exhale breath hold (EBH), abdominal compression (AC), free breathing gating (gating) and free breathing (FB), and the impact of these on treatment time. MATERIALS AND METHODS: We assessed all patients treated in a single institution with liver SBRT between September 2017 and September 2021. Data from pre-simulation motion management assessment using fluoroscopic assessment of liver dome position in repeat breath holds, and motion with and without AC, was reviewed to determine liver dome position consistency in EBH and the impact of AC on motion. Treatment time was assessed for all fractions as time from first image acquisition to last treatment beam off. RESULTS: Of 136 patients treated with 145 courses of liver SBRT, 68 % were treated in EBH, 20 % with AC, 7 % in gating and 5 % in FB. AC resulted in motion reduction < 1 mm in 9/26 patients assessed. Median treatment time was higher using EBH (39 min) or gating (42 min) compared with AC (30 min) or FB (24 min) treatments. CONCLUSIONS: Motion management in liver SBRT needs to be assessed per-patient to ensure appropriate techniques are applied. Motion management significantly impacts treatment time therefore patient comfort must also be taken into account when selecting the technique for each patient. Elsevier 2023-01-04 /pmc/articles/PMC9841271/ /pubmed/36655214 http://dx.doi.org/10.1016/j.phro.2022.12.004 Text en © 2022 Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Hardcastle, Nicholas
Gaudreault, Mathieu
Yeo, Adam U.
Ungureanu, Elena
Markham, Cathy
Barnes, Rebecca
Chander, Sarat
Chu, Julie
Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
title Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
title_full Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
title_fullStr Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
title_full_unstemmed Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
title_short Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
title_sort selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841271/
https://www.ncbi.nlm.nih.gov/pubmed/36655214
http://dx.doi.org/10.1016/j.phro.2022.12.004
work_keys_str_mv AT hardcastlenicholas selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime
AT gaudreaultmathieu selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime
AT yeoadamu selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime
AT ungureanuelena selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime
AT markhamcathy selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime
AT barnesrebecca selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime
AT chandersarat selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime
AT chujulie selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime